[Federal Register Volume 85, Number 21 (Friday, January 31, 2020)]
[Notices]
[Page 5670]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01809]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Centers for Disease Control and Prevention 
(CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and STD 
Prevention and Treatment (CHAC) has scheduled a public meeting. 
Information about CHAC can be found at https://www.cdc.gov/maso/facm/facmCHACHSPT.html.

DATES: March 5, 2020, 3:00 p.m.--4:00 p.m. Eastern Time (ET).

ADDRESSES: This meeting will be held by webinar and will accommodate up 
to 100 attendees. To access the virtual meeting, please use the 
information below.
     Webinar link: https://hrsa.connectsolutions.com/chac_business_meeting/
     Conference call-in number:
    [cir] Call in: 888-790-1964.
    [cir] Passcode: 1251991.

FOR FURTHER INFORMATION CONTACT: Theresa Jumento, Public Health 
Advisor, HIV/AIDS Bureau, HRSA, 5600 Fishers Lane, Rockville, Maryland 
20857; 301-443-5807; or [email protected].

SUPPLEMENTARY INFORMATION: CHAC was established under Section 222 of 
the Public Health Service (PHS) Act, [42 U.S.C. Section 217a], as 
amended.
    The purpose of CHAC is to advise the Secretary of HHS, the Director 
of CDC, and the HRSA Administrator regarding objectives, strategies, 
policies, and priorities for HIV, viral hepatitis, and other STDs; 
prevention and treatment efforts including surveillance of HIV 
infection, viral hepatitis, other STDs, and related behaviors; 
epidemiologic, behavioral, health services, and laboratory research on 
HIV, viral hepatitis, and other STDs; identification of policy issues 
related to HIV/viral hepatitis/STD professional eduction, patient 
healthcare delivery, and prevention services; agency policies about 
prevention of HIV, viral hepatitis and other STDs; treatment, 
healthcare delivery, and research and training; strategic issues 
influencing the ability of CDC and HRSA to fulfill their missions of 
providing prevention and treatment services; programmatic efforts to 
prevent and treat HIV, viral hepatitis, and other STDs; and support to 
the agencies in their developoment of responses to emerging health 
needs related to HIV, viral hepatitis, and other STDs.
    During the March 5, 2020, meeting, CHAC will discuss issues related 
to a CDC pilot on recency assay-based incidence estimation and the 
President's initiative on ``Ending the HIV Epidemic: A Plan for 
America.'' Agenda items are subject to change as priorities dictate.
    Due to the nature and time limitations of the meeting, members of 
the public will not have an opportunity to provide oral comments, 
although written comments may be submitted prior to the meeting, or up 
to 5 business days after the meeting, to Theresa Jumento at the contact 
information listed above. Individuals who plan to attend and need 
special assistance or another reasonable accommodation should notify 
Theresa Jumento at the address and phone number listed above at least 
10 business days prior to the meeting.

Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2020-01809 Filed 1-30-20; 8:45 am]
 BILLING CODE 4165-15-P